Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8(+) T cell responses

Influenza vaccines that can be administered intranasally or by other needle-free delivery routes have potential advantages over injected formulations in terms of patient compliance, cost, and ease of global distribution. Supramolecular peptide nanofibers have been investigated previously as platform...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Youhui, Wen, Yi, Kelly, Sean H., Chong, Anita S., Collier, Joel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309200/
https://www.ncbi.nlm.nih.gov/pubmed/29673645
http://dx.doi.org/10.1016/j.jconrel.2018.04.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309200/
https://www.ncbi.nlm.nih.gov/pubmed/29673645
http://dx.doi.org/10.1016/j.jconrel.2018.04.031

Ejemplares similares